Introduction
============

The *Streptococcus* Anginosus/Milleri Group (SAG) is a group of three distinct yet closely related species: *S. anginosus, S. constellatus*, and *S. intermedius*. The species *S. anginosus* is divided into *S. anginosus* subsp. *anginosus* and *S. anginosus* subsp. *whileyi* while the species *S. constellatus* is divided into *S. constellatus* subsp. *constellatus, S. constellatus* subsp. *pharyngis* and *S. constellatus* subsp. *viborgensis* ([@B31]). In humans, the SAG lead a dual lifestyle as both commensals and pathogens. These strains can be found asymptomatically colonizing the oral cavity as well as the gastrointestinal and urogenital tracts ([@B47]; [@B59]; [@B30]). However, they are also important pyogenic pathogens involved in empyema and soft tissue abscesses ([@B50]; [@B59]; [@B14]; [@B37]; [@B49]; [@B55]; [@B5]) as well as infections of the lower airways ([@B52]; [@B45]; [@B54]). The SAG can be difficult to culture and identify ([@B50]; [@B53]) and are underappreciated pathogens. They have been associated with more invasive pyogenic infections than Group A and Group B *Streptococcus* combined ([@B37]; [@B55]).

Host colonization involves competition with resident microorganisms. One mechanism by which streptococci inhibit closely related bacteria is through short peptides called bacteriocins ([@B16]). Variable bacteriocin and putative bacteriocin genes are found adjacent to the *sil* locus in GAS, and these are predicted to be under the regulatory control of SilA ([@B7]). The *Streptococcus* Invasion locus (*sil*) system was first identified in Group A Streptococci (GAS), where a transposon insertion in the *sil* system attenuated virulence in a murine model ([@B28]). The core signaling system has been characterized and contains the cell--cell signaling peptide SilCR, a peptide processing/export system (SilD/E), and two component sensing system (SilA/B). Upon sensing pheromone peptide SilCR, the histidine kinase SilB phosphorylates the response regulator SilA, upregulating genes involved in SilCR production. These include the SilCR peptide itself and ABC transporters, SilD and SilE. SilC is encoded on the antisense strand of *silCR* and its expression represses SilA-inducible genes in GAS ([@B28]; [@B20]). SilA/B transcriptional regulation is uncharacterized, but induction of the *sil* system is dependent on their presence and expression ([@B20]). The system also includes a putative CAAX protease, thought to be involved in immunity against or maturation of bacteriocins.

The *sil* system has been implicated in virulence in GAS ([@B28]; [@B51]). Disruption of *silC* leads to attenuation in a murine model ([@B28]). As SilC represses SilCR induction, the lack of the pheromone peptide appears to favor pathogenesis. However, interspecies communication occurring between GAS and Group G streptococci (GGS) via SilCR peptide positively regulates SilCR and bacteriocins ([@B7]). Thus, regulation of this system in streptococci is complex and can impact pathogenesis in multiple ways.

The *sil* system has not been characterized in SAG. Here, we describe the *sil* system in 42 SAG genomes, outlining species-specific variation and identification of novel putative bacteriocins. We note this locus as a hotspot for genetic variability with most strains featuring a large cluster of putative bacteriocin/immunity genes. We demonstrate that the inhibitory activity of SilCR-dependent putative bacteriocins can give *S. intermedius* a competitive advantage.

Materials and Methods {#s1}
=====================

Strains
-------

Forty-four assembled SAG genomes were used for our analysis (Supplementary Table [S1](#SM1){ref-type="supplementary-material"}). Seven of these were previously published complete, closed genomes (C1050, C1051, C818, C232, C270, C238, B196; [@B44]), and 26 were unpublished draft genomes (see below). The strains of these 26 new genomes have been described in [@B33]. The SAG *sil* regions have been deposited in GenBank (accession numbers KY315440-KY315481) (Supplementary Table [S1](#SM1){ref-type="supplementary-material"}). Eleven draft genomes were also downloaded from NCBI ([@B8]) (ADME01000005.1, AP013072.1, AJKN01000015.1, AICP01000048.1, AFXO01000004.1, NC 018073.1, AFUP01000001.1, AICQ01000033.1, AFXN01000007.1, AREF01000001.1, AECT01000012.1).

Assembly and Strain Cluster Assignment
--------------------------------------

The in-house draft genomes were all sequenced using NexteraXT libraries and Illumina MiSeq using either 150 or 250 bp paired-end reads. The sequences were assembled using our in-house genome assembly pipeline \[Surette Lab Assembly Pipeline (SLAP)\]. SLAP preprocesses the reads by trimming adapters with Cutadapt ([@B42]) and performing quality trimming and error correction with sga preprocess and sga correct ([@B56]). It then estimates an optimal kmer size using an in-house adaptation of the program Kmergenie ([@B12]), and calls four separate assemblers \[MaSuRCA ([@B63]), IDBA ([@B46]), SPAdes ([@B6]), and Velvet ([@B62])\] to produce four candidate assemblies. The assemblies are then scaffolded using SSPACE ([@B11]) and quality metrics are provided to the user via FastQC ([@B3]) for read quality and QUAST ([@B24]) for assembly quality. For our purposes, the best assembly was chosen for each strain based on N50 value and total assembly length. All in-house code is available from the authors upon request.

We assigned our samples to strain clusters following [@B31]. We found each of the seven housekeeping genes used in the paper in all of our strains. The SAG accession numbers for *map* (KY274883 -- KY274924), *pfl* (KY274925 -- KY274966), *ppaC* (KY274967 -- KY275008), *pyk* (KY275009 -- KY275050) *rpoB* (KY275051 -- KY275092), *sodA* (KY275093 -- KY275133), and *tuf* (KY275134 -- KY275175) are as indicated. All genes were present in all samples with the exception of *sodA*, which was absent from C1051. These genes were aligned with the trimmed sequences used by [@B31], trimmed to the same length, and a phylogenetic tree was constructed using MEGA 7.0.20 using default parameters with the following exceptions: we used a minimum-evolution model with 500 bootstrap replicates and pairwise deletion for missing data.

Identifying the Putative *sil* Region in SAG
--------------------------------------------

The putative *sil* system was identified in the published genome of *S. intermedius* B196 (Accession number: NC_022246.1) based on its structural similarity to the GAS and GGS *sil* locus. We used megablast ([@B2]) to find each gene from this putative *sil* locus in the 44 additional SAG genomes. We found the genes together on a single contig in 42 genomes (aside from *S. intermedius* B196) and split across multiple contigs in two genomes (M1 and C424, which we excluded from our analysis). A list of the 42 strains used for our analysis is provided in Supplementary Table [S1](#SM1){ref-type="supplementary-material"}. The 42 putative *sil* regions were annotated from the BLAST hits using in-house Python and Biopython scripts ([@B58]; [@B13]) with manual adjustments, and the annotations were visualized and compared using Geneious ([@B34]).

Phylogenetic Trees
------------------

A phylogenetic tree of the *sil* locus was generated using MrBayes ([@B29]; [@B1]). Each gene (*silA* through *silD*) was aligned individually using MUSCLE ([@B19]) and the alignments were concatenated (with gaps in place of the nucleotides for missing genes), providing a single alignment of all genes. The genes were each assigned their own partition in the MrBayes model, with a 4-by-4 General Time Reversible evolutionary model ([@B57]) and invariant/gamma rates distribution ([@B61]) for each partition. Since many sequences were missing individual genes, the presence or absence of each gene was encoded as binary "standard" data in a separate partition ([@B39]). The trees were run until the average standard deviation of the split was less than 0.01 and the consensus tree was visualized using the Interactive Tree of Life (iTOL) ([@B38]).

Annotating the Bacteriocin Region
---------------------------------

The putative bacteriocin region adjacent to the *sil* region was annotated using the online version of antiSMASH ([@B10], [@B9]) accessed November of 2013. Only the results of the antiSMASH-internal GLIMMER ([@B17]) annotation were used. In order to determine how variable the accessory regions are, the sequences from the GLIMMER hits were translated and preliminary clustering was undertaken using OrthoMCL ([@B22]). This produced 16 putative orthologous groups, here referred to as ORF1 through ORF16. To identify any pseudogenes or related ORFs not discovered by GLIMMER, we manually divided each cluster into smaller groups based on the MUSCLE alignment of the cluster (if multiple groups were apparent) and generated a consensus sequence for each group. We searched naively for each of these consensus sequences in all of the bacteriocin regions (tolerant to 20% mismatch at the amino acid level).

We generated a tree for each of the 16 ORF clusters produced by OrthoMCL using FastTree ([@B48]). The location of each putative accessory gene in each strain was marked and patterns of synteny were manually examined.

We searched for each ORF in the non-redundant protein sequences (nr) database with Blastx ([@B2]) to identify putative functions. In addition, each ORF was searched against the BACTIBASE database ([@B25], [@B26]) of bacteriocins to identify hits with existing bacteriocins.

Bacterial Culturing Conditions
------------------------------

We cultured *S. intermedius* B196 and *S. constellatus* M505 on Todd Hewitt agar with 0.5% yeast extract (THY) and incubated at 37°C in a 5% CO~2~ incubator for 3 days. We inoculated THY broth with colonies and incubated either at 5% CO~2~ or anaerobically (5% CO~2~, 5% H~2~, 90% N~2~) at 37°C overnight. We used broth cultures to conduct further experiments. THY supplemented with 75 μg/ml spectinomycin (THY-spec) was used to grow our knockout strain (see below). We used *Escherichia coli* Top10 chemically competent cells (Life Technologies) during cloning. *E. coli* carrying desired knockout constructs grew on Luria-Bertani agar with 100 μg/mL spectinomycin (LB-spec).

Identification of SilA Binding Sites in *S. intermedius* B196
-------------------------------------------------------------

Binding of response regulator SilA to direct repeats in GAS and GGS affects expression of *sil* locus components as well as putative bacteriocins ([@B28]). The SilA binding site in GAS (ACCATTCATG-11bp-ACCTTTTAAG) ([@B7]) was used as a query to identify putative sites in *S. intermedius* B196 using the motif search in Geneious ([@B34]). The ClustalW 2.1 alignment of these sites ([@B23]) was used to generate an *S. intermedius* B196 consensus sequence, visualized using WebLogo ([@B15]).

SilCR Knockout Construction
---------------------------

We constructed a deletion mutant of *silCR* in *S. intermedius* B196. First, we cloned the spectinomycin resistance marker from pDL278 ([@B18]) along with its promoter into pUC19 with primers specF and specR as shown in **Table [1](#T1){ref-type="table"}**. We then cloned the upstream and downstream regions of *silCR* in *S. intermedius* on either side of a spectinomycin resistance marker in pUC19 using primers SilCRupF, SilCRupR, SilCRdownF, and SilCRdownR (**Table [1](#T1){ref-type="table"}**). We amplified the cassette (*silCR* upstream: *specR*: *silCR* downstream) using PCR with primers SilCRupF and SilCRdownR and purified it. Our laboratory has found that *S. intermedius* B196 is naturally competent and can be transformed using the competence stimulating peptide, ComC (DSRIRMGFDFSKLFGK) (data not shown). An overnight THY broth culture was diluted 1000 fold in 500 μL THY and incubated for 2 h at 37°C in 5% CO~2~ before adding competence peptide (10 ng) and purified cassette DNA (500 ng). The reaction was incubated in normal growth conditions for an hour before plating the transformation reaction on THY- spec. We incubated the plates for 2 days anaerobically at 37°C and screened colonies using PCR and sequencing to verify the deletion.

###### 

Primers used for *silCR* knockout construction and Real time PCR.

  Knockout construction                                               
  ----------------------- ------------------------------------------- ---------
  specF                   AAAAA[GGATCC]{.ul}GACGAAGAGGATGAAGAGG       *Bam*HI
  specR                   AAAAA[GTCGAC]{.ul}CCCAAATATTAAATAATAAAAC    *Sal*I
  SilCRupF                AAAAA[GAGCTC]{.ul}CAAAAAGCAATACTGAAGT       *Sac*I
  SilCRupR                AAAA[GGATCC]{.ul}CATGTATTATTATAACCCGAC      *Bam*HI
  SilCRdownF              AAAA[GTCGAC]{.ul}CTAAAAATACAAATAACCTCATTG   *Sal*I
  SilCRdownR              AAAA[GCATGC]{.ul}CTTCTCTCTATTTTTACATCAG     *Sph*I
                                                                      
  **Real time PCR**                                                   
                                                                      
  **Primer**              **Sequence (5′--3′)**                       
                                                                      
  SilCRF                  ACAAACATTGGATCATTTTCGTACACTCAC              
  SilCRR                  AGCCTAATGTATTATTTGAATCTCCCTTTGTTAAAC        
  SilEF                   GAATTACCAATGTCTTTTTTTGCTACGAGACG            
  SilER                   GTCAAGAAAGAGTGAAAGTATTGTAGAAGCG             
  ORF1F                   CTCACTCGAAAAATTTGAAGTACTGAACTCC             
  ORF1R                   CCATGTTGCGGCTAAACAAGTATAATGTG               
  ORF16F                  TGAATACAAAAACATTGGAAAAATTTGAAGCACTG         
  ORF16R                  GGTCTTGATTCCTAATCTCAATCCATTACCTG            
  SodAF                   CGGCAAGGCTTTAGAACAACTTTTAGC                 
  SodAR                   CTTCTGGTGTCATCAATTCCCAAAAAAGAC              
  DnaKF                   AAGTTATCTTGGTTGGTGGG                        
  DnaKR                   AGGGTTTACTGATTTGTTTGG                       
  RecAF                   CTGCATCTATCAATAAAACGAAGAC                   
  RecAR                   AGCGAACTGAAGCATAAAAC                        

Bacteriocin Activity Assays
---------------------------

To assess bacteriocin activity, we adapted top-agar overlay experiments ([@B36]; [@B41]). *S. intermedius* B196 (the bacteriocin producer) and mutant strain were grown in an overnight anaerobic broth culture as previously described. A volume of 4 μL of the overnight culture was spotted on THY agar and incubated in the anaerobe chamber at 37°C for 2 days. In some cases, synthetic SilCR peptide was spotted along with culture. SilCR peptide was synthesized by RS Synthesis, LLC (Louisville). The amount of peptide added was dependent on the experiment. *S. constellatus* M505, which lacks the bacteriocin cluster and *caax* gene, was used as a bacteriocin-sensitive strain. This was grown anaerobically in THY for 24 h. Top agar (THY) was prepared using 1.5% agar as this higher percentage improved the visualization of the zone of clearing. A 100 μL of overnight broth culture of *S. constellatus* M505 was added to 5 mL molten Top agar and inverted three times before pouring onto the agar plates with *S. intermedius* spots. Plates were incubated for 1--2 days at 5% CO~2~ at 37°C.

Relative Real Time PCR
----------------------

To assess SilCR dependent expression of putative bacteriocins, we designed primers for specific genes in the *sil* locus and reference genes (molecular chaperone *dnaK* and recombinase *recA*) (**Table [1](#T1){ref-type="table"}**). Biological replicates of *S. intermedius* B196 and mutant were grown and spotted on THY agar as described, with and without synthetic SilCR peptide. After 16 h of growth in the anaerobic chamber at 37°C, bacterial spots were resuspended in RNAlater Solution (Ambion). Bacterial RNA was purified using enzymatic lysis, TRIzol (Invitrogen) and the RNeasy mini kit (Qiagen) as described in [@B21]. To eliminate DNA contamination, samples were treated with the RNase free DNase set (Qiagen) and subsequently purified using the RNeasy mini columns (Qiagen). RNA was normalized using readings from the Nanodrop prior to cDNA preparation using the SuperScript^®^ III first-strand cDNA synthesis system for RT-PCR (Invitrogen) as per manufacturer's instructions. SsoFast^TM^ Evagreen^®^ Supermix (Bio-Rad) was used for real time PCR as per manufacturer's instructions. Real-time PCR was conducted on the CFX96 Touch^TM^ Real-time PCR detection system (Bio-Rad). Thermal cycling conditions included an initial 95°C for 30 s and 39 cycles of 95°C for 5 s and 55°C for 5 s. The gene expression level of sample groups was normalized to wild type *S. intermedius* B196 without SilCR peptide and calculated using the ΔΔCT method in CFX manager (Bio-Rad).

Results
=======

Identification of the *sil* System in *S. intermedius* B196
-----------------------------------------------------------

We have previously sequenced and annotated the genome for the clinically isolated strain *S. intermedius* B196 ([@B44]). We identified a region with structural similarity to the *sil* region previously identified in GAS and GGS. This region contains five of the six genes included in the GAS/GGS *sil* locus (*silA, silB, silCR, silD*, and *silE*), with the same relative positioning and orientation (**Figure [1A](#F1){ref-type="fig"}**). The locus is bounded by a putative [D]{.smallcaps}-Ala-[D]{.smallcaps}-Ala carboxypeptidase (SIR_RS15545) at one end and *sodA* at the other. Adjacent to the carboxipeptidase is a conserved hypothetical protein (SIR_RS15550) that has a thioredoxin-like domain. This is followed by 13 small ORFs containing putative bacteriocins, followed by a gene with homology to CAAX proteases. Downstream of the CAAX protease are the *sil* genes including *silA, silB, silCR, silD*, and *silE*. We did not find evidence for a counterpart to *silC* in *S. intermedius* B196 based on nucleotide similarity to GAS *silC*. While there is an open reading frame (ORF) on the antisense strand of SilCR, there is no evidence that it is transcribed or plays any role in *sil* regulation. More research is required to conclude if this is *silC*.

![**The predicted Sil system in *Streptococcus intermedius* B196. (A)** The organization of the *sil* locus showing the signal peptide gene (*SilCR*) and signaling transduction genes (*silAB* and *silED*) in green. The associated locus genes including putative CAAX protease is shown in blue and bacteriocin associated gene clusters are indicated in color. The positions of predicted SilA binding sites are as indicated. **(B)** The predicted SilA binding site and consensus sequence. **(C)** Schematic illustration of the *sil* regulatory network in the *Streptococcus* Anginosus Group based on the *sil* system in Group A *Streptococcus* ([@B20]; [@B7]).](fmicb-07-02156-g001){#F1}

Comparison between the *S. intermedius* B196 and GAS *sil* systems revealed sequence divergence despite the overall similar organization of the *sil* loci. Although, the putative *sil* region in *S. intermedius* B196 shares its structure with that found in *Streptococcus pyogenes* AF493605.1 ([@B28]), these genes have low rates of sequence identity. *S. intermedius* B196 SilA is only 49.4% identical (85.7% similar) to GAS SilA in amino acid sequence (60.0% nucleotide identity). B196 SilB is 34.6% identical and 73.9% similar to GAS SilB (53.7% nucleotide identity). B196 SilCR is 28.0% identical and 68.0% similar to GAS SilCR (47.8% nucleotide identity). B196 SilD is 56.2% identical and 90.3% similar to GAS SilD (63.6% nucleotide identity). Finally, B196 SilE is 74.5% identical and 88.6% similar to GAS SilE (68.5% nucleotide identity).

In other streptococci, the *sil* system and putative bacteriocins are transcriptionally regulated by response regulator SilA and the SilCR pheromone peptide ([@B28]). The SilA binding site in GAS (ACCATTCATG-11bp-ACCTTTTAAG) was used to find putative SilA binding sites in the *S. intermedius* B196 *sil* locus, as highlighted in **Figure [1A](#F1){ref-type="fig"}**. Direct repeats were found upstream of *silCR, silE, caax, SIR_RS15550* and in the accessory region upstream of *ORF1, ORF15*, and *ORF16*. The predicted operator was conserved in all of these genes except CAAX protease, which had inconsistencies in the second repeat (**Figure [1B](#F1){ref-type="fig"}**).

A schematic for the hypothetical regulation of the *sil* system in SAG is shown in **Figure [1C](#F1){ref-type="fig"}**. The predicted regulatory network functions as follows. SilCR is produced by SAG species and exported. Sensing of extracellular SilCR peptide induces SilB to autophosphorylate and phosphorylate response regulator SilA. SilA, in turn, induces expression of the seven genes indicated in **Figure [1B](#F1){ref-type="fig"}**. Induction of these genes is predicted to amplify the response via SilCR dependent autoregulation and induce production of bacteriocins which can inhibit closely related bacteria.

Bacteriocin Activity in *S. intermedius* B196 is Regulated by SilCR
-------------------------------------------------------------------

We investigated the role of the *sil* system in inter-species competition using *S. intermedius* B196 as a model. A putative SilA binding site was found upstream of putative bacteriocins ORF1, ORF15, and ORF16 (**Figure [1](#F1){ref-type="fig"}**). To investigate whether SilCR regulates bacteriocin expression in *S. intermedius* B196, we constructed a *silCR* deletion mutant. We assayed bacteriocin activity by spotting *S. intermedius* B196 and its mutant on THY agar and after growth, applying a top agar overlay of a sensitive strain, *S. constellatus* M505. Strain M505 was chosen because it lacks the *sil* accessory region (see below) and we therefore predicted it would lack immunity genes and be sensitive to SilCR-dependent bacteriocins produced by B196. When M505 was overlaid in top agar over B196, a clear zone of growth inhibition was observed (**Figure [2A](#F2){ref-type="fig"}**). This activity is lost in the B196 Δ*silCR* mutant (*S. intermedius* B196 Δ*silCR*; **Figure [2A](#F2){ref-type="fig"}**). Exogenous addition of the synthetic SilCR peptide from B196 (SilCR~SAG-A~) restored the wild type phenotype, demonstrating that SilCR induces production of an inhibitor of strain M505.

![**Bacteriocin-mediated competition in *S. intermedius* is controlled by the SilCR peptide.** The gene for the pheromone peptide SilCR was deleted in *S. intermedius* B196 (*S. intermedius* B196 Δ*silCR*). **(A)** Competition in the wild type and mutant was ascertained using an overlay of sensitive strain *S. constellatus* M505. The two identified SAG SilCR peptides were exogenously added to wild type and mutant and the diameter of the inhibition zone measured as shown. **(B)** Relative reverse transcription PCR on B196 and B196Δ*silCR* for experiment shown in **(A)** without the M505 overlay (^∗^*p* \< 0.005). **(C)** A concentration dependent induction of bacteriocin activity by SilCR peptides A and B in *S. intermedius* B196. Note the B196 colony diameter is ∼6.5 mm. SilCR~SAG-A~ induced zones are significantly larger than those with SilCR~SAG-B~ (^∗^*p* \< 0.005).](fmicb-07-02156-g002){#F2}

In order to identify whether deletion of *silCR* affected gene expression of the putative bacteriocins ORF1 and ORF16, we conducted relative real-time PCR on the wild type and mutant strains (**Figure [2B](#F2){ref-type="fig"}**). We used spotted B196 and B196 Δ*silCR* with and without exogenously added SilCR~SAG-A~ for our analysis. Deletion of *silCR* downregulated expression of gene *silE* and putative bacteriocins *ORF1* and *ORF16* in the samples tested. Addition of SilCR ~SAG-A~ to the knockout induced expression of *ORF1, ORF16* and *silE* by 61-, 43-, and 138-fold respectively; demonstrating that SilCR regulates expression of putative bacteriocins *ORF1* and *ORF16* and these are putatively involved in inhibition of *S. constellatus* M505.

Comparative Genomic Analysis of the *sil* Locus Separates SAG Strains into Two *silCR* Peptide Groups
-----------------------------------------------------------------------------------------------------

We investigated the distribution of the *sil* system in SAG. Forty four SAG strains were used in our analysis: a combination of in-house sequenced genomes and those available online. Only genomes containing the *sil* genes on a single contig were analyzed (42 of the 44 genomes; as listed in Supplementary Table [S1](#SM1){ref-type="supplementary-material"}). We used the multilocus sequence analysis (MLSA) described by [@B31] to assign our strains into seven designated clusters for SAG. Our MLSA tree reproduced the clusters found by [@B31] with our new strains neatly nested within six of the seven clusters. Strain cluster assignments are included in **Figure [3](#F3){ref-type="fig"}** and the MLSA phylogeny is shown in Supplementary Figure [S3](#SM2){ref-type="supplementary-material"}.

![***sil* locus heterogeneity in the *Streptococcus* Anginosus Group (SAG).** A tree was constructed based on *sil* genes in 42 strains. Six locus arrangements were found (shown in locus arrangement legend with the locus annotation). Hashes (//) in the annotation indicate a putative bacteriocin accessory region. Two SilCR peptides were identified, shown in the peptide legend. SAG species text is color coded (*S. intermedius* in orange, *S. anginosus* in gray, and *S. constellatus* in green). The accessory region ORFs are shown with the tree. Some ORFs have several versions, indicated by the letter inside the ORF. Genes that have acquired mutations leading to pseudogenes in some strains and are indicated in the figure.](fmicb-07-02156-g003){#F3}

Initial investigation of the *sil* sequences divided SAG strains into two groups. In 24 of the 42 genomes, both *silB* and *silCR* appeared truncated; *silB* at the 5′ end and *silCR* at the 3′ end. Further examination, however, found that this 5′ end of *silB* was well-conserved in 22 of the 24 strains. In addition, results from a BLAST search of this region showed high identity with histidine kinases, which is consistent with the putative function of SilB. Indeed, the gene had been annotated as such in at least one of the published genomes in our data set (protein accession YP 008494978 from genome C232), implying that we had found a variation of *silB*. These 22 strains also had a well-conserved region following their truncated *silCR*. A stop codon located 150 bp from the start of *silCR* was used to define the variation of putative *silCR*. Thus, we identified two distinct SilCR peptides in SAG, SilCR~SAG-A~ and SilCR~SAG-B~ (previously truncated version), with predicted mature amino acid sequences GWLEDLLKHFSGYNSLTKGDSNNTLG and GWLEDLFSPYLKKYKLGKLGQPDLG, respectively. Notably, each SilCR peptide allele associated exclusively with a corresponding variant of histidine kinase SilB. This suggests that the response by a strain could be dependent on the kinase variant. The conserved 5′ end of SilCR propeptide is hypothetically cleaved at the double glycine residues to produce the mature SilCR peptide.

To investigate whether *S. intermedius* B196 could respond to the alternative peptide, SilCR~SAG-B~ was added to the knockout (**Figure [2A](#F2){ref-type="fig"}**). Despite high peptide concentrations, SilCR~SAG-B~ induced a smaller inhibitory zone in M505 than did SilCR~SAG-A~ (8 mm vs. 11 mm). To further test the peptide dependent bacteriocin induction of strain B196, several concentrations of each peptide were used. We found that higher concentrations of SilCR~SAG-B~ were required to produce inhibitory zones comparable to those produced by SilCR~SAG-A~ (**Figure [2C](#F2){ref-type="fig"}**). Thus, while strain B196 can sense and respond to both pheromone SilCR peptides produced by SAG strains, its inhibitor production is peptide- and concentration- dependent requiring high concentration of the non-cognate signaling peptide to elicit a response.

To investigate the phylogeny of the *sil* locus in the 42 SAG genomes, the gene presence, sequence, and orientation were used to construct a tree (**Figure [3](#F3){ref-type="fig"}**). The tree of *sil* genes corresponded well with SAG species. Six different organizations of the *sil* locus were noted in SAG, as depicted in the locus arrangement legend in **Figure [3](#F3){ref-type="fig"}**. The type of SilCR peptide the strain produced (SilCR~SAG-A~ vs. SilCR~SAG-B~) is also indicated in the figure. Strains encoding SilCR~SAG-A~ have low diversity overall and are monophyletically nested within *S. intermedius*, while all three species can encode SilCR~SAG-B~. In 32 of the 42 *sil* loci, we identified the canonical arrangement of the *sil* locus (locus arrangement A in **Figure [3](#F3){ref-type="fig"}**). This arrangement is found in strains carrying SilCR~SAG-A~ and SilCR~SAG-B~ and is the arrangement seen in *S. intermedius* B196 (**Figure [1A](#F1){ref-type="fig"}**). The additional *sil* locus arrangement groups are characterized by the loss of genes and when SilCR is present, only included SilCR~SAG-B~. Locus group B is defined by an intact *sil* region but is altered next to *silE* with *sodA* absent and includes a single *S. anginosus* strain. The other arrangements of the *sil* region (C-D) are represented by deletions leading to loss of core *sil* genes. Group C consists of a single *S. constellatus* strain and is defined by missing *silE* and *sodA*. Group D is represented by one *S. constellatus* strain and one *S. intermedius* strain and is characterized by missing a number of *sil* locus components including the putative bacteriocin region, CAAX protease and *silA* response regulator. Group E is composed of only *S. anginosus* strains, and is characterized by the lack of all *sil* genes and accessory proteins except *silD, silE*, and *sodA*, with an inversion in *silD* and *silE* relative to *sodA*. Group F includes a single *S. anginosus* strain and is identical to Group E but missing *silE*. Overall, the *S. anginosus* strains had the most variation in composition of the *sil* locus with all locus groups represented except Groups C and D.

We identified a few strains where one or more *sil* genes had undergone inactivating mutations. A number of these pseudogenes appear to be the result of a few single mutation events and are consistent with the *sil* tree (**Figure [3](#F3){ref-type="fig"}**). In strains SK54, ATCC27335, and JTH08 (sister taxa in our *sil* gene phylogeny), *silCR* has a single-nucleotide deletion at base 12. In strains C1366 and C1384 (also sister taxa), *silCR* has a different single-nucleotide deletion at base 14. The *sil* system is otherwise intact in these strains. In strains C188, C232, and C818 (three of six sisters in an unresolved node in our phylogeny), the secretion protein *silD* has a single-nucleotide deletion at base 1314. These strains also have otherwise-intact *sil* regions. In addition to these, a small number of individual strains do not share *sil* gene inactivation events with other strains in our data set. Strain M410 has a partial *sil* region (containing *silE, silD*, and *sodA* only) and a single nucleotide deletion at base 972 in *silE*. Strain CCUG39159 has an intact *sil* region and an SNP that introduces a stop codon at base 1342. Strain M47 appears to have undergone a larger genome rearrangement event, with a 70 Kb region intervening between partial *silD* and *silE* genes. Strains M423, 1_2\_62CV, and C270 have different frameshift mutation events in non-*sil* genes (SIR_RS15550 for the first, CAAX for the latter two). Finally, strain SK1060 appears to be degenerate in several places; the SIR_RS15550 homolog contains a single nucleotide insertion at base 95, while CAAX, *silA, silB*, and *silD* contain deletions at bases 558, 18, 136, and 1107 respectively.

Heterogeneity in the *sil* Accessory Bacteriocin Region Implies Strain Specific Competition
-------------------------------------------------------------------------------------------

The *Streptococcus sil* system controls expression of competitive bacteriocins in GAS ([@B20]; [@B7]; [@B4]). In *S. intermedius* B196, we observe that bacteriocin activity is dependent on this signaling system. We discovered a highly variable accessory region in all strains carrying *sil* locus groups A-C (34 of the 42 genomes). We investigated the hypothetical ORFs in this region for putative bacteriocin and immunity genes. Sixteen distinct orthologous groups were identified using OrthoMCL. A detailed similarity comparison within each orthologous group is included in the Supplementary Similarity Files. The amino acid identity heatmap for each ORF is shown in the Supplementary Figures. In general, while some ORFs are highly conserved within SAG, others are not. For example, ORF13 is conserved with 97% or higher amino acid identity across 28 strains while ORF2 is clearly divided into two groups with one group having 44% amino acid identity to the other. Using this classification scheme, it was apparent that some strains had two copies of predicted ORFs (e.g., ORF4 in *S. anginosus* 1_2\_62CV; **Figure [3](#F3){ref-type="fig"}**). It is important to note that the two copies are not identical and, given their patterns of synteny, it is not likely that they are functionally equivalent.

We assigned putative functions to the 16 ORFs identified based on similarity to hits in the non-redundant protein sequence database using BlastX (NCBI). These are summarized in **Table [2](#T2){ref-type="table"}**. In total, six putative bacteriocins were identified (ORF1, ORF2, ORF6, ORF8, ORF15, and ORF16). Of the six bacteriocins, two were highly similar to existing bacteriocins (ORF2 is similar to bovicin 255 and ORF15 is similar to ThmA bacteriocin). The non-bacteriocin ORFs may have chaperone or immunity functions. ORFs 4 and 7 had high similarity with a bacteriocin secretion protein and a bacteriocin immunity gene, respectively. ORF3 has a putative role in replication. ORF14 shares some nucleotide identity with a tRNA (cytidine/uridine-2′-*O*-)- methyltransferase. It is unknown whether ORF14 serves a similar function in SAG. Six of the putative ORFs did not have predicted functions (ORFs 5, 9, 10, 11, 12, and 13). Characterization of these genes is required to gain insight into their role. However, some speculation based on the patterns of co-occurrence with other genes is possible. Several of the strains have acquired mutations in some of these accessory genes that has led to pseudogenes. These include two predicted bacteriocin genes (ORF1 and ORF2), several genes with no assigned function (ORF3, ORF9, ORF10, and ORF12) and one gene assigned to bacteriocin secretion function (ORF4). No pseudogenes were detected in any of the predicted immunity genes.

###### 

Bioinformatic analysis of identified putative bacteriocin accessory region ORFs using a sequence search against the non-redundant protein sequence database using BlastX (NCBI).

  ORF   BlastX best hit                                                          Cover   Identity   Score   E-value   Accession
  ----- ------------------------------------------------------------------------ ------- ---------- ------- --------- ----------------
  1     Bacteriocin; Class IIc                                                   99%     99%        145     3e-43     WP_006267535.1
  2     Bovicin 255 variant; Class II                                            71%     62%        85.9    2e-20     AAR02622.1
  3     Role in replication                                                      97%     67%        119     4e-32     WP_030127173.1
  4     Bacteriocin secretion protein                                            57%     37%        46.2    7e-04     EWM55695.1
  5     Hypothetical protein                                                     98%     88%        145     5e-43     WP_020998893.1
  6     Bacteriocins class II with double glycine leader peptide                 88%     54%        67.8    1e-13     KEQ38561.1
  7     Bacteriocin immunity protein                                             98%     99%        194     2e-61     WP_006267076.1
  8     Bacteriocin class II with double glycine leader peptide family protein   88%     94%        137     4e-40     WP_009568291.1
  9     No hits                                                                                                       
  10    No hits                                                                                                       
  11    Hypothetical protein                                                     98%     100%       62.4    5e-11     WP_021002964.1
  12    No hits                                                                                                       
  13    Hypothetical protein                                                     84%     53%        42.7    3e-4      EWM55551.1
  14    tRNA (cytidine/uridine-2′-*O*-)- methyltransferase TrmJ                  50%     46%        37.4    0.39      WP_059746670.1
  15    ThmA bacteriocin; Class IIc                                              98%     63%        82      7e-19     KIQ75182.1
  16    Bacteriocin BlpU; Class IIc                                              72%     70%        76.6    5e-17     WP_021143664.1

There were some clear patterns of synteny in the accessory regions of the *sil* loci (**Figure [3](#F3){ref-type="fig"}**). These became more apparent after taking the subclusters of each ORF into consideration. We describe the syntenic groupings of ORFs as "ORF sets" (OS) because the operon structures have not been established for these strains. In combination with our putative functional assignments, we attempted to characterize these ORF sets (Supplementary Figure [S1](#SM2){ref-type="supplementary-material"}) in order to group bacteriocins with co-occurring genes that may be functionally associated with them. All ORF sets except OS IX contain at least one putative bacteriocin (Supplementary Figure [S1](#SM2){ref-type="supplementary-material"}). Three ORFs occurred only once each across all strains and are labeled "other" (**Figure [3](#F3){ref-type="fig"}**). Putative bacteriocin ORF1A is exclusively found adjacent to ORF5A, while ORF1B is separated from ORF5B by bacteriocin ORF2 and its associated genes. The two versions of putative bacteriocin ORF2 were found in two distinct clusters, OS III and OS V. ORF2 is always associated with a version of the putative secretion protein, ORF4. It is also always adjacent to either the putative immunity gene ORF7 or the unknown ORF10, suggesting an immunity function for the latter. Putative bacteriocin ORF6 is always found adjacent to ORF3, implying ORF3 may confer immunity against ORF6. A version of ORF3 is also found associated with ORF2 in OS V. It may be that ORF3, rather than ORF7, confers immunity to ORF2A. Putative bacteriocin ORF8 was found adjacent to ORF12 in most strains (although ORF12 has been mutated to a pseudogene in some of these strains). ORF12 was not present in strains lacking ORF8 and may therefore be only required in the presence of ORF8. Uncharacterized ORF9 is associated with two putative bacteriocins (ORF15 and 16) in two separate ORF sets (OS I and OS II). In each case, the genes are also associated with a hypothetical protein of unknown function (ORFs 11 and 13, respectively). None of the strains carried all six putative bacteriocins, implying that each strain may be susceptible to at least one bacteriocin. A number of *S. intermedius* strains had five predicted bacteriocins (**Figure [3](#F3){ref-type="fig"}**) implying that this species has high competitive potential. *S. constellatus* C1367 and *S. anginosus* C423 also had five predicted bacteriocins.

The arrangements of ORF sets within the accessory regions correspond imperfectly with the *sil* tree, indicating a large amount of recombination or horizontal gene transfer is occurring within this region. OS I is found in a majority of strains. The six strains lacking OS I form a monophyletic group with low genetic distance in the *sil* region, indicating a recent loss event. Areas of apparent recombination are highlighted with pink boxes in **Figure [3](#F3){ref-type="fig"}**. OS I occurs at one end of the bacteriocin accessory region in the strains where it is present. OS II is found on five genomes, in two positions relative to other ORF sets. OS IV typically appears at the downstream end of accessory regions where it is found (except in strains C1369 and B196), while OS III may be at the downstream end or may be upstream of OS VI. OS V occurs either upstream of OS II or OS III. In either case it is directly downstream of OS I.

Discussion
==========

In GAS and GGS, the *Streptococcus sil* system senses and responds to pheromone peptide SilCR with induction of endogenous SilCR production and expression of bacteriocins. In some streptococci, expression of *silCR* is inhibited by expression of *silC*, which is encoded on the antisense strand at the 3′ end of *silCR*. In those organisms, it has been shown that *silC* expression can repress SilCR-activated promoters ([@B28]; [@B20]). No conserved *silC* ORF across all *silCR*+ strains of SAG was found and more research is required to identify if there is a *silC* variant in SAG.

The prevalence of the *sil* locus within GAS is low, with only 4 out of the 19 fully sequenced genomes of GAS carrying it. Remnants of the locus have been left behind in strains that do not ([@B35]; [@B43]; [@B32]). The prevalence is higher in GGS, with all sequenced strains carrying a functional SilCR gene ([@B7]; [@B43]). Our analysis of SAG showed that the majority of the strains sequenced carry the locus. Locus arrangement Groups A and B in **Figure [3](#F3){ref-type="fig"}** shows that all components of the locus are present in most SAG strains, although individual genes do appear to be degenerate in some strains. The other groups included few strains and, like GAS, showed loss of some *sil* genes. Further study is needed to determine whether the lack of a fully functional *sil* system affects a strain's competitive fitness or ability to colonize or invade.

In SAG, considerably higher genetic heterogeneity was seen in the bacteriocin accessory region than in the *sil* gene region. *S. anginosus* displayed the most variation in the presence of *sil* genes, implying that the locus may not be under stabilizing selection and may not be required for competition in this species. Conversely, most *S. intermedius* and *S. constellatus* strains were included in locus group A, suggesting that the *sil* locus may be more competitively necessary in these species, at least in the clinical context from which these strains were isolated.

The bacteriocins identified in the SAG *sil* locus have not been characterized or directly associated with intra- or interspecies competition; however, the identification of six putative bacteriocins within the *sil* locus in SAG is a new finding. Bacteriocins can mediate competition with closely related bacteria and can provide a competitive advantage during *in vivo* colonization experiments ([@B16]). ORF2 is a homolog of bovicin 255, which has been shown to inhibit growth of select streptococci ([@B60]). ORF15 is homologous to thermophilin 13 bacteriocin (ThmA), which is produced by *S. thermophilus* and can inhibit a broad range of Gram-positive bacteria including spore formers ([@B40]). In addition to these genes, four more putative bacteriocins were identified and remain to be characterized. The species selectivity of these putative bacteriocins in SAG is currently being investigated.

Interspecies SilCR induction of SilA-responsive genes has been described previously between GAS and GGS ([@B7]). Inter- and intra- species competition in streptococci can occur in a polymicrobial environment such as the oral cavity. The hypothetical mature SilCR~SAG-A~ and SilCR~SAG-B~ peptides are 26 and 25 amino acids respectively, while the mature GAS peptide is 17. Both SAG immature peptides have the same six amino acids at their 5′ end but vary at their 3′ end. The SAG SilCR peptides are not very similar to the GAS and GGS SilCR peptides in either sequence or length and it remains to be determined if these species' *sil* systems are cross-reactive.

Our data demonstrates that *S. intermedius* B196 can sense and respond to SilCR~SAG-B~, which can be carried by all three SAG species; however, a much higher concentration of the foreign peptide SilCR~SAG-B~ was required to rescue the phenotype in B196Δ*silCR* than the B196-native version (SilCR~SAG-A~). This implies a divergent co-evolution of the *silCR* and *silB* genes in the SAG-A clade, with selection for self-detection.

SilCR expression has been shown to attenuate virulence in a mouse model of necrotizing fasciitis ([@B28], [@B27]). However, SilA has also been shown to promote expression of virulence-associated genes including streptolysin S, iron transporter SiaA and serine protease ScpC ([@B51]). It is unknown whether the *sil* system in SAG affects its pathogenicity. This system is unusual in that it can contribute to both infection in the host and bacterial competition depending on the environment. Given the host-specificity of SAG, and the commensal and pathogenic roles it can play, further analysis of this system could deepen our understanding of SAG competition and its associated clinical diseases.
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